NGM Biopharmaceuticals Inc
NGMDelisted Apr 5, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426332
NGM Biopharmaceuticals Inc was delisted on Apr 5, 2024; its insiders filed their last Form 4 on Apr 8, 2024; 75 institutions reported holding it in 13F filings for Q1 2024, worth $55.1M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in NGM Biopharmaceuticals Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 95
- −11 vs. Q2 2023
- Shares held
- 47.1M
- −887.8K (−1.8%) vs. Q2 2023
- Total value
- $50.6M
- −$73.8M (−59.3%) vs. Q2 2023
- New holders
- 12
- 30 more added
- Sold out
- 23
- 35 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 75 | $55.1M |
| Q4 2023 | 83 | $35.3M |
| Q3 2023 | 95 | $50.6M |
| Q2 2023 | 106 | $124.4M |
| Q1 2023 | 123 | $200.4M |
| Q4 2022 | 125 | $248.9M |
| Q3 2022 | 128 | $689.9M |
| Q2 2022 | 124 | $607.3M |
| Q1 2022 | 114 | $732.8M |
| Q4 2021 | 119 | $833.5M |
| Q3 2021 | 121 | $951.2M |
| Q2 2021 | 107 | $849.7M |
| Q1 2021 | 108 | $1.25B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding NGM Biopharmaceuticals Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −31,431−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −32,352−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −28,895−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −23,031−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −21,464−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −19,603−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −17,511−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −15,738−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −15,400−100.0% | Sold out |
| Grantham, Mayo, Van Otterloo & Co. LLC | 0 | $0 | 0.00% | −14,397−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −13,095−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −12,676−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −12,193−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,416−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,246−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −452−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −106−100.0% | Sold out |